Sanofi news

19 April 2016
Sanofi Invests €300M in Belgium Site to Expand Monoclonal Antibodies Portfolio
€300M investment will expand production capabilities, add new labs, and increase floor space by 8000 m². The site will support a pipeline of biologics, including monoclonal antibodies.
12 November 2015
Sanofi Expands in Höchst
Investing €200M, the company will build a fully automated cold warehouse and a multi-purpose building for medical tech, creating 500 jobs and expanding insulin production capabilities.
1 February 2011
Sanofi Opens Cell Culture Plant in Höchst
The new plant, costing EUR 30 million, will produce monoclonal antibodies for trials, doubling production capacity and enhancing the company's biopharmaceutical focus and market position.

What's Sanofi up to in Europe?

Find out with chemXplore Analytics